Arkolith/Insider Trading/LEXX/Form 4/A

Bunka Christopher

Chief Executive Officer, DirectorLexaria Bioscience Corp. (LEXX) · full profile →Form 4/A · filed Oct 18, 2022
Net Buying
Open-Market Buys
$78K
Open-Market Sells
$0
Net Open-Market Flow
$78K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 13, 2022Buy(P)17K$2.10$35K254K
Oct 12, 2022Buy(P)22K$1.99$44K238K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001855763-22-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML